← Back to Search

Brain Stimulation + Gait Training for Stroke Recovery

N/A
Recruiting
Led By Sangeetha Madhavan
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than 18 years
Walking speed lesser than 1.2 m/s
Must not have
Lesions involving the brainstem and cerebellum
Uncontrolled anti-spasticity medications during the study period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to immediately after training and baseline to 3 months follow up

Summary

This trial is testing a brain stimulation protocol to improve walking outcomes in people with stroke. The goal is to understand the neural mechanisms associated with response to the intervention.

Who is the study for?
This trial is for adults who've had their first stroke more than 3 months ago, can walk at least 5 minutes with or without a walking aid but slower than 1.2 m/s, and have some movement in the affected leg. They shouldn't have severe muscle stiffness, major heart or lung diseases, certain mental impairments, skin conditions worsened by stimulation, metal head implants, pacemakers, recent concussions or be pregnant.
What is being tested?
The study tests if brain stimulation combined with ankle exercises and high-speed treadmill training improves walking after a stroke. It also looks into how the brain changes with this treatment. Participants will receive transcranial direct current stimulation (tDCS) alongside physical therapy interventions.
What are the potential side effects?
Possible side effects include mild discomfort or itching under the electrode during tDCS; fatigue from physical exercises; and risks associated with intense exercise like shortness of breath or increased heart rate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I walk slower than 1.2 meters per second.
Select...
I can move my ankle upwards at least 5 degrees.
Select...
I have difficulty walking due to partial paralysis.
Select...
My leg movement is moderately impaired.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer has spread to my brainstem or cerebellum.
Select...
I am not taking any uncontrolled anti-spasticity medications.
Select...
I frequently have headaches without a known cause.
Select...
I have a history of seizures or epilepsy.
Select...
I do not have any unhealed sores or ongoing infections.
Select...
I experience increased sensitivity or pain from touch.
Select...
I do not have uncontrolled heart, lung, or metabolic conditions.
Select...
I am taking medication that could make me more prone to seizures.
Select...
I have stiffness in my leg that limits its movement.
Select...
I have a skin or scalp condition that might worsen with tDCS treatment.
Select...
I have severe osteoporosis.
Select...
I have skull abnormalities or fractures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to immediately after training and baseline to 3 months follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to immediately after training and baseline to 3 months follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Walking speed with 10 meter walk test
Secondary study objectives
Aerobic capacity
Ankle motor control
Ankle range of motion
+12 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Priming+HIISTTExperimental Treatment3 Interventions
Facilitatory transcranial direct current stimulation (tDCS) and ankle motor training before high intensity interval speed based treadmill training
Group II: Sham+HIISTTPlacebo Group1 Intervention
Sham tDCS before high intensity interval speed based treadmill training

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,696 Total Patients Enrolled
20 Trials studying Stroke
2,325 Patients Enrolled for Stroke
University of Maryland, College ParkOTHER
158 Previous Clinical Trials
46,268 Total Patients Enrolled
6 Trials studying Stroke
564 Patients Enrolled for Stroke
Northwestern UniversityOTHER
1,649 Previous Clinical Trials
958,578 Total Patients Enrolled
34 Trials studying Stroke
25,331 Patients Enrolled for Stroke

Media Library

High intensity interval speed based treadmill training (HIISTT) Clinical Trial Eligibility Overview. Trial Name: NCT04477330 — N/A
Stroke Research Study Groups: Priming+HIISTT, Sham+HIISTT
Stroke Clinical Trial 2023: High intensity interval speed based treadmill training (HIISTT) Highlights & Side Effects. Trial Name: NCT04477330 — N/A
High intensity interval speed based treadmill training (HIISTT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04477330 — N/A
~19 spots leftby Dec 2025